Stock Events

Stock Events

Karyopharm Therapeutics (25K0.F) Q2 2026 Earnings

30AprConfirmed

Q3 2025

Q4 2025

Q1 2026

Next

-4.81

-3.61

-2.41

-1.21

Details

Expected EPS

-1.21056606489

Actual EPS

N/A

Surprise EPS

1.21

Surprise Percent

+100%

Description

Karyopharm Therapeutics (25K0.F) will report earnings of for Q2 2026 on April 30, 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.